Skip to content
mapperlab
← Dashboard
Stock

BCE

BCE INC
Latest close $247 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
7
27 funds tracked
Ever held
9
Current + past
New this quarter
0
Exited this quarter
1

Marquee-fund ownership over time

Aug 13, 2013Aug 12, 2020Feb 14, 2025May 15, 2026
Now
7

This quarter's activity

New positions opened

None.

Positions exited

Current holders

Sorted by tenure (longest first)
FundEntry priceLatest closeReturn on entry
Bridgewater Associates re-entered$20$24+20%
Citadel Advisors$30$24-21%
D.E. Shaw$30$24-21%
Millennium Management re-entered$30$24-21%
Two Sigma Investments$22$24+9%
AQR Capital Management$24$24-2%
Renaissance Technologies$26$24-7%

“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.

Past holders

Funds that exited at some point
FundEntry → ExitReturn
Point72 Asset Management→ $24-7%
Maverick Capital→ $30-5%

Insider activity

Form 4 — officers, directors, 10%+ owners

Filed within two business days of each transaction by anyone with material insider status at BCE INC. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.

Filings · last 30d
1
Filings · last 90d
1
Total on file
1
Recent SEC buffer
Most recent
Mar 9, 2007

30d / 90d windows measured from Mar 9, 2007 — the most recent Form 4 on file — not from today.

Fundamentals

XBRL · BCE INC

Not enough XBRL history to plot. BCE INChasn't tagged revenue, net income, EPS, or operating cash flow in the SEC us-gaap taxonomy with at least two fiscal-year periods — typical for SPACs / trust vehicles, pre-revenue biotechs, recent IPOs, and foreign filers reporting under IFRS.

Recent SEC filings

10-K · 10-Q · 8-K · 13D/G · proxy

The most recent material filings for BCE INC — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.

Trade history

Every open→close lifecycle across tracked funds
FundOpen dateClose dateOpen priceClose price / currentReturn
Point72 Asset ManagementQ1 2026Q2 2026$25$24-7%
Renaissance TechnologiesQ1 2026open$26$24-7%
Bridgewater AssociatesQ4 2025open$23$25+9%
AQR Capital ManagementQ3 2025open$24$24-2%
Millennium ManagementQ3 2025open$24$24-2%
Two Sigma InvestmentsQ1 2025open$22$24+9%
Citadel AdvisorsQ3 2024open$30$24-21%
D.E. ShawQ3 2024open$30$24-21%
Millennium ManagementQ3 2024Q2 2025$30$21-32%
Maverick CapitalQ1 2024Q2 2024$31$30-5%
Bridgewater AssociatesQ2 2023Q2 2025$38$20-47%
Bridgewater AssociatesQ3 2021Q1 2022$37$39+5%
Bridgewater AssociatesQ3 2017Q3 2020$27$29+8%
Bridgewater AssociatesQ3 2015Q2 2016$22$26+17%
Bridgewater AssociatesQ1 2015Q2 2015$23$23+1%
Bridgewater AssociatesQ3 2013Q2 2014$20$23+16%
Caveats
  • Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
  • Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
  • “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
  • Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
  • Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.